$3 Million EUROTAPES Program Grant from European Union for Further Development and Advancement of Second Generation HTS Tapes
HANAU, Germany--(BUSINESS WIRE)--Sep. 28, 2012-- Bruker Energy & Supercon Technologies, Inc. (BEST) announced today that its wholly owned Bruker HTS GmbH subsidiary has received a 2.3 million Euro (approximately $3 million USD) grant from the European Commission's Directorate-General for Research & Innovation under the EUROTAPES project. The project to further improve the performance of high temperature superconductor (HTS) tape includes a total of 20 consortium partners from eight European countries - including eight industrial companies, six universities, five institutes, and one technological center. As the leading industrial partner for the project's scale-up efforts, Bruker HTS received the largest amount of funding on the program, which is coordinated by the Spanish National Research Council CSIC - ICMAB (Consejo Superior de Investigaciones Científicas - Institut de Ciència de Materials de Barcelona). The scheduled duration of the project is 54 months, beginning on September 1, 2012.
BEST is investing significant resources in the development and scale-up of its proprietary YBCO HTS tape, and plans to spend approximately 4.4 million Euro in the execution of its work tasks under the EUROTAPES program. The overall EUROTAPES program has a budget of 20 million Euro, of which 13.5 million Euro is being funded by the European Union.
The objective of EUROTAPES is to identify the best HTS conductor design and most efficient processes for HTS YBCO coated conductors, utilizing a combination of physical and chemical methods while also using two types of substrates - IBAD/ABAD (Ion/Alternating Beam Assisted Deposition) coated stainless steel and RABiTSTM (Rolling Assisted Biaxial Textured Substrates). The consortium partners will exchange tapes at different process stages for further processing using alternative methods. Bruker HTS will focus on the assessment of new technologies and processes, as well as implementation and up-scaling of best layer and process combinations.
Dr. Klaus Schlenga, Senior Vice President and CTO of BEST, said: "We are very pleased that this project has been granted. It strengthens long-term partnerships, and it provides the basis for all of us to benefit from the vast experience that exists within this carefully composed consortium. This project matches up perfectly with our existing strategy to develop a cost and performance optimized HTS YBCO process."
Professor Dr. Xavier Obradors, EUROTAPES project coordinator and Director of ICMAB, added: "The project is an excellent opportunity to advance a very fruitful cooperation between European partners from academia and industry in the field of the development of advanced nanostructured second generation coated conductors. Certainly the know-how complementarities and the achieved critical mass will contribute to push European industry towards an international leadership position in high-tech sectors related to electrical power infrastructures and medical or biomedical equipment."
For more information on the EUROTAPES program, please visit: http://eurotapes.eu/
About Bruker Energy & Supercon Technologies, Inc. (BEST)
BEST is a subsidiary of Bruker Corporation (NASDAQ: BRKR), and is a leader in the development and industrial manufacturing of advanced superconducting materials and superconducting devices for alternative energy, smart grid, healthcare and 'big science' applications. For more information on BEST, please visit www.bruker-est.com.
CAUTIONARY STATEMENT OF BEST
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," "continue" or other similar words.
These forward-looking statements are predictions, not guarantees. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to materially differ from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those projected, include, but are not limited to, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, intellectual property rights, litigation, and exposure to foreign currency fluctuations. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as guarantees of future events.
The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.
Source: Bruker Energy & Supercon Technologies, Inc.
Dr. Klaus Schlenga
Bruker Energy & Supercon Technologies, Inc.
Senior Vice President & CTO